Making cancer drugs better
Killian Award recipient Stephen Lippard describes his work on platinum-based chemotherapy agents.
Killian Award recipient Stephen Lippard describes his work on platinum-based chemotherapy agents.
A look back at how Institute Professor Phillip Sharp, his startup Biogen, and MIT’s biotech community helped revive Kendall Square.
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
Study reveals immune cells that are critical to combating the parasite in early stages of infection.
MIT is one of six institutions receiving a total of $540 million to provide reliable, long-term support for high-impact, innovative research.
Studying these cells could lead to new treatments for diseases ranging from gastrointestinal disease to diabetes.
The professors were recognized by their peers for their efforts to advance science or its applications.
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.
MIT researchers find a way to boost lithium-air battery performance, with the help of modified viruses.
Simple urine test developed by MIT engineers uses nanotechnology to detect dangerous blood clotting.
Mice with human immune cells help researchers discover how the mosquito-borne virus depletes blood platelets.
Particles that deliver vaccines directly to mucosal surfaces could defend against many infectious diseases.
New findings could lead to drugs that fight back when tumors don’t respond to treatment.
Engineered liver tissue developed at MIT could help scientists test new drugs and vaccines.